May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Differential Modulation of HIF1 Function in RF/6A and HUVEC cells.
Author Affiliations & Notes
  • E.G. Rojo–Niersbach
    Ophthalmics, Novartis Institutes for Biomedical Research, Basel, Switzerland
  • A. Ottlecz
    Ophthalmics, Novartis Institutes for Biomedical Research, Basel, Switzerland
  • H. Buehler–Nurmi
    Ophthalmics, Novartis Institutes for Biomedical Research, Basel, Switzerland
  • G. Lambrou
    Ophthalmics, Novartis Institutes for Biomedical Research, Basel, Switzerland
  • Footnotes
    Commercial Relationships  E.G. Rojo–Niersbach, Novartis Pharma AG E; A. Ottlecz, Novartis Pharma AG E; H. Buehler–Nurmi, Novartis Pharma AG E; G. Lambrou, Novartis Pharma AG E.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 665. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E.G. Rojo–Niersbach, A. Ottlecz, H. Buehler–Nurmi, G. Lambrou; Differential Modulation of HIF1 Function in RF/6A and HUVEC cells. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):665.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:The kinetics of HIF1 in activating vascular endothelial growth factor (VEGF) expression was analysed in distinct cell lines. Methods:RF/6A rhesus monkey choroid–retinal and human umbilical vein cord (HUVEC) endothelial cells were incubated under hypoxic conditions for 1, 2, 4, and 8 hours and treated with the phosphoinositol–3 (PI–3) kinase inhibitor LY294002 (Calbiochem) or vehicle. Cells and culture media were harvested after each hypoxic timepoint. Nuclear extracts were used in 1) electrophoretic mobility shift assays (EMSA) with the hypoxia–inducible–factor–1 (HIF1) elements in the vascular endothelial growth factor (VEGF) and promoter and 2) Western Blots for HIF1 detection. VEGF release was determined by enzyme–linked immunoabsorbent assay (ELISA). Results: Conclusions:

Keywords: retinal neovascularization • hypoxia • choroid: neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×